<DOC>
	<DOCNO>NCT00001301</DOCNO>
	<brief_summary>Non-Hodgkin 's lymphoma study Pediatric Branch least 20 year , time number different treatment protocol use . Approximately 110 patient apparently cure lymphoma . The present protocol therapeutic component , design document late effect may encounter patient , either consequence disease treatment . In essence , patient consent participate ask series question pertain quality life possible medical problem may encounter . In addition , receive complete physical examination undergo non-invasive investigation design identify presence unsuspected late effect . Investigators Eye Clinic , Dental Clinic , Audiology , Cardiology Endocrinology department participate protocol . As part study , blood sample obtain investigate possibility predispose genetic factor may identifiable patient normal cell ( e.g. , p53 mutation , evidence DNA instability ) . If abnormality detect , blood sample family member also examine determine whether defect inherit .</brief_summary>
	<brief_title>Chronic Late Effects Non-Hodgkin 's Lymphoma Its Treatment Long Term Survivors</brief_title>
	<detailed_description>Non-Hodgkin 's lymphoma study Pediatric Branch least 20 year , time number different treatment protocol use . Approximately 110 patient apparently cure lymphoma . The present protocol therapeutic component , design document late effect may encounter patient , either consequence disease treatment . In essence , patient consent participate ask series question pertain quality life possible medical problem may encounter . In addition , receive complete physical examination undergo non-invasive investigation design identify presence unsuspected late effect . Investigators Eye Clinic , Dental Clinic , Audiology , Cardiology Endocrinology department participate protocol . As part study , blood sample obtain investigate possibility predispose genetic factor may identifiable patient normal cell ( e.g. , p53 mutation , evidence DNA instability ) . If abnormality detect , blood sample family member also examine determine whether defect inherit .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>Patients histologic diagnosis small noncleaved cell ( undifferentiated ) ( SNCL ) , lymphoblastic ( LL ) , large cell lymphoma ( LCL ) treat accord National Cancer Institute Pediatric Branch nonHodgkin 's lymphoma protocols 740 , 756 , 765 , 7704 , 85C67 , 89C41A , continuous remission one year longer follow completion treatment . Patients relapse successfully retreat exclude , except patient lymphoblastic lymphoma retreat accord acute lymphoblastic leukemia protocol .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1999</verification_date>
	<keyword>Adverse Effects</keyword>
	<keyword>Burkitt 's Lymphoma</keyword>
	<keyword>Diffuse Large Cell Lymphoma</keyword>
	<keyword>Extended Remission</keyword>
	<keyword>Health Status</keyword>
	<keyword>Lymphoblastic Lymphoma</keyword>
	<keyword>Molecular Studies</keyword>
</DOC>